We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

BioVendor Group

BioVendor Group is an international group of biotechnology companies (BioVendor LM, BioVendor R&D, TestLine, ViennaLa... read more Featured Products: More products

Download Mobile App





BioVendor Group Demonstrates Unique IVD Platform and Immunoblot Test

By LabMedica International staff writers
Posted on 15 Nov 2023
Print article
Image: BioVendor is demonstrating its latest IVD solutions at MEDICA 2023 (Photo courtesy of BioVendor)
Image: BioVendor is demonstrating its latest IVD solutions at MEDICA 2023 (Photo courtesy of BioVendor)

BioVendor Group (Brno, Czech Republic) is demonstrating its IVD solutions in the form of a CLIA platform, a new generation of a unique immunoblot test for effective multiplex diagnostics, Microblot-Array, or its comprehensive sequencing solution using the NGS method at MEDICA 2023. MEDICA is the world's largest medical trade fair of all - with several thousand exhibitors from more than 60 nations in the exhibition halls. A wide range of innovative products and services from the fields of medical imaging, laboratory technology, diagnostics, health IT, mobile health as well as physiotherapy/orthopedic technology and medical consumables are being presented here.

At this year’s MEDICA, BioVendor is demonstrating the KleeYa fully automated analyzer which is versatile, fast, smooth, and intuitive, working like a perfectly coordinated orchestra. The operator is only required to set, run, and exit with KleeYa taking care of the rest and operating independently for a long time, thanks to the high-capacity consumable containers. With a graphical user interface, the operator can learn to control the fully automated system in minutes. Additionally, KleeYa software is designed to minimize the burden on laboratory staff. BioVendor is also highlighting Microblot–Array (MBA), a new generation of unique, immunoblot arrays in a microtiter plate format. It is designed for efficient multiplex diagnostics, enabling the simultaneous detection of multiple markers which can save time and lower costs. The technology eliminates the limited capacity of traditional BLOT strips and opens the opportunity for high throughput testing.

Processing can be performed automatically using open ELISA analyzers. The evaluation is performed by the Microblot–Array Reader and software (SW). Results can be exported in various formats and the system can be connected to LIS. In addition, BioVendor is showcasing its new fastGEN technology for the examination of the mutation status of oncomarkers in samples. The technology is based on ultra-deep sequencing of short amplicons obtained by a single polymerase chain reaction with specially tagged hybrid primers. The fastGEN technology is simple, ultra-sensitive, specific, and effective - it is perfectly adapted to diagnostics and offers new advantages for clinical material.

Related Links:
BioVendor Group 

Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
Silver Member
Static Concentrator
BJP 10
New
Flu Test
ID NOW Influenza A & B 2

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: QScout CBC will give a complete blood count in 2 minutes from fingerstick or venous blood (Photo courtesy of Ad Astra Diagnostics)

Next Gen CBC and Sepsis Diagnostic System Targets Faster, Earlier, Easier Results

Every hour is critical in protecting patients from infections, yet there are currently limited tools to assist in early diagnosis before patients reach a hospital. The complete blood count (CBC) is a common... Read more

Immunology

view channel
Image: An immune response is initiated when an antigen-presenting cell (pink) presents foreign material to a T-cell (blue) (Photo courtesy of JAX)

Advanced Imaging Method Maps Immune Cell Connections to Predict Cancer Patients Survival

A growing tumor is influenced not only by the tumor cells themselves but also by the surrounding tissue, which alters its biology. Immune cells communicate by transferring vital signaling proteins to their... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more

Pathology

view channel
Image: LMU’s Professor Frederick Klauschen developed the novel approach that can improve diagnostic accuracy (Photo courtesy of LMU Munich)

AI Tool Uses Imaging Data to Detect Less Frequent GI Diseases

Artificial intelligence (AI) is already being utilized in various medical fields, demonstrating significant potential in aiding doctors in diagnosing diseases through imaging data. However, training AI... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.